Maureen Dubreuil, MD, MSc.

Dr. Dubreuil is a rheumatologist in Boston, specializing in Spondyloarthritis. She works within the Rheumatology section at Boston University School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. In 2013, she was awarded the Arthritis Foundation Clinical to Research Transition Award and 2016, she began work on a K23-funded project to study patient preferences, and the cost-effectiveness of treatment modalities for spondyloarthritis, to inform both clinical care and policy decisions. She serves as Education Chair and Board Member for the Spondyloarthritis Research and Treatment Network (SPARTAN), is a Medical Advisor for the Spondylitis Association of America, and is a member of the Assessment of Spondyloarthritis International Society (ASAS). She is a site investigator for the international CLASSIC study and the PULSAR spondyloarthritis registry.

Boston University
Arthritis & Autoimmune Diseases Research Center

VA Boston Healthcare System

2020-2022 NIH/NIAMS R03: Risk of Fractures & Joint Replacement Surgeries w/TNF-inhibitors in Ank. Spondylitis
2018 Spondylitis Association of America: Early Career Investigator Award
2018 Spondyloarthritis Research and Treatment Network Seed Grant Awardee
2017 Boston University: Evans Junior Merit Award
2016-2021 NIH/NIAMS K23: Establishing the Value of Treatment Strategies in Ankylosing Spondylitis
2016-2020 Boston University School of Public Health and Optum Labs Visiting Scholar
2015-2020 Boston University Department of Medicine: Career Investment Award
2013-2015 Arthritis Foundation: Research Scientist Development Award
2009 Gold Humanism in Medicine Award

Risk of fractures, joint replacements and adverse pregnancy outcomes in ankylosing spondylitis
07/01/2020 - 06/30/2022 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases

Establishing The Value of Treatment Strategies in Spondyloarthritis
05/01/2016 - 04/30/2022 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases

Classification of Axial SpondyloarthritiS Inception Cohort (CLASSIC)
12/23/2019 - 12/22/2020 (PI)
SpondyloArthritis Research and Treatment Network

Cardiovascular disease and diabetes in Ankylosing Spondylitis
07/01/2013 - 12/30/2015 (PI)
Arthritis Foundation

Boston University Advanced Fellowship in Psoriatic Arthritis Clinical and Research Excellence
07/01/2020 - 06/30/2021 (PI)
Pfizer, Inc


Boston University Clinical and Translational Science Institute
01/01/2019 - 12/31/2020 (PI)

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Meer E, Thrastardottir T, Wang X, Dubreuil M, Chen Y, Gelfand JM, Love TJ, Ogdie A. Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: A set of parallel case-control studies. J Rheumatol. 2021 Aug 01. PMID: 34334358
  2. Stovall R, Peloquin C, Felson D, Neogi T, Dubreuil M. Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study. BMC Rheumatol. 2021 Jul 29; 5(1):36.View Related Profiles. PMID: 34321112; DOI: 10.1186/s41927-021-00207-1;
  3. Kumthekar A, Bittar M, Dubreuil M. Educational needs and challenges in axial spondyloarthritis. Curr Opin Rheumatol. 2021 07 01; 33(4):313-318. PMID: 33973547
  4. Jinno S, Onishi A, Dubreuil M, Hashimoto M, Yamamoto W, Murata K, Takeuchi T, Kotani T, Maeda Y, Ebina K, Son Y, Amuro H, Hara R, Katayama M, Saegusa J. Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study. Arthritis Res Ther. 2021 04 15; 23(1):116. PMID: 33858490; DOI: 10.1186/s13075-021-02496-w;
  5. Stovall R, Peloquin C, Felson D, Neogi T, Dubreuil M. Relation of NSAIDs, DMARDs, and TNF Inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee Arthroplasty. J Rheumatol. 2021 Jul; 48(7):1007-1013.View Related Profiles. PMID: 33452168
  6. Karmacharya P, Shahukhal R, Crowson CS, Murad MH, Davis JM, Shrestha P, Bekele D, Wright K, Chakradhar R, Dubreuil M. Effects of Therapies on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Rheumatol Ther. 2020 Dec; 7(4):993-1009. PMID: 33170493; DOI: 10.1007/s40744-020-00248-x;
  7. Karmacharya P, Duarte-Garcia A, Murad MH, Dubreuil M, Shahukhal R, Shrestha P, Myasoedova E, Crowson CS, Wright K, Davis JM. Reply. Arthritis Rheumatol. 2020 12; 72(12):2164-2165. PMID: 32686914
  8. Fraenkel L, Buta E, Suter L, Dubreuil M, Levy C, Najem C, Brennan M, Corn B, Kerns R, Goulet J. Nonsteroidal Anti-inflammatory Drugs vs Cognitive Behavioral Therapy for Arthritis Pain: A Randomized Withdrawal Trial. JAMA Intern Med. 2020 09 01; 180(9):1194-1202. PMID: 32702101; DOI: 10.1001/jamainternmed.2020.2821;
  9. Jinno S, Onishi A, Dubreuil M, Akashi K, Hashimoto M, Yamamoto W, Murata K, Takeuchi T, Kotani T, Maeda Y, Ebina K, Son Y, Amuro H, Hara R, Katayama M, Saegusa J, Morinobu A. Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study. Rheumatol Int. 2020 Dec; 40(12):1987-1995. PMID: 32728836
  10. Liew JW, Dubreuil M. Treat to Target in Axial Spondyloarthritis: Pros, Cons, and Future Directions. Rheum Dis Clin North Am. 2020 05; 46(2):343-356.View Related Profiles. PMID: 32340706; DOI: 10.1016/j.rdc.2020.01.011;
Showing 10 of 43 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 44 publications over 12 distinct years, with a maximum of 7 publications in 2018 and 2020

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Spondyloarthritis, Ankylosing
Psoriatic Arthritis
Spondyloarthritides, Ankylosing

I have mentored Master-level SPH students and fellows in projects related to epidemiology of rheumatologic diseases and pharmacoepidemiology. These projects have culminated in publications, a Master degree thesis, as well as poster and oral presentations at national meetings. I hope to continue mentoring trainees who have interests in epidemiology related to specific research projects, development of research themes, or development of grant applications.

Available to Mentor as: (Review Mentor Role Definitions):
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
Dubreuil's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department